Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network.

被引：0
|
作者：
Neubauer, M. A.
Garey, J. S.
Nelson, G. C.
Patt, D. A.
Cartwright, T. H.
Hoverman, J. R.
Busby, L. T.
Brooks, B. D.
Sitarik, M. A.
Kolodziej, M. A.
Anderson, R. W.
Beveridge, R. A.
机构：
[1] US Oncol, Kansas City Canc Ctr, The Woodlands, TX USA
[2] US Oncol Pathways Task Force, The Woodlands, TX USA
[3] US Oncol, The Woodlands, TX USA
[4] Ocala Oncol, Ocala, FL USA
[5] US Oncol, Texas Oncol, The Woodlands, TX USA
[6] US Oncol, Rocky Mt Canc Ctr, Boulder, CO USA
[7] US Oncol, New York Hematol Oncol, Albany, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e16527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16527
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Vaccines as adjuvant therapy for non-small cell lung cancer (NSCLC)
    Butts, Charles
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S220 - S221
  • [32] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [33] Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology
    Sankawa, Yuri
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (03) : 149 - 149
  • [34] Management of locally advanced non-small cell lung cancer (NSCLC) at a community hospital: A retrospective analysis
    Spranklin, Laura Jane
    Heflin, Jon Willis
    Calvo, Alejandro R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Platinum-based Doublet Chemotherapy plus Bevacizumab Without Bevacizumab Maintenance in Advanced Non-small Cell Lung Cancer (NSCLC)
    Noroxe, Dorte Schou
    Wallerek, Sandra
    Sorensen, Jens Benn
    ANTICANCER RESEARCH, 2013, 33 (08) : 3275 - 3278
  • [36] Bevacizumab: Its Place in the Treatment of Advanced Non-small Cell Lung Cancer
    Agarwal, V.
    Prasad, R.
    Butt, M.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 715 - 725
  • [37] Bevacizumab treatment for advanced non-small cell lung cancer: A case report
    Fan, Yun
    Huang, Zhiyu
    Mao, Weimin
    ONCOLOGY LETTERS, 2013, 6 (06) : 1779 - 1783
  • [38] Brain metastases in advanced non-small cell lung cancer post bevacizumab
    Huang Yujuan
    Yang Jinji
    Wang Zhen
    Huang Yisheng
    Wu Yilong
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S684 - S684
  • [39] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Surgical Outcomes in a Regionalized Pulmonary Oncology Network
    Pilon, Y.
    Rokah, M.
    Rayes, R. F.
    Cools-Lartigue, J.
    Najmeh, S.
    Sirois, C.
    Mulder, D.
    Ferri, L.
    Abdulkarim, B.
    Ezer, N.
    Fraser, R.
    Camilleri-Broet, S.
    Fiset, P. -O.
    Wong, A.
    Sud, S.
    Langleben, A.
    Agulnik, J.
    Pepe, C.
    Shieh, B.
    Hirsh, V.
    Ofiara, L.
    Owen, S.
    Spicer, J. D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S290 - S290
12345